Pfizer ( PFE) said Wednesday that it has hired Frank D'Amelio as its new chief financial officer, effective in mid-September.

D'Amelio replaces Alan Levin, who announced his resignation in May.

Since 1979, D'Amelio has worked in the telecommunications field. Most recently, he was senior executive vice president and chief administrative officer at Alcatel-Lucent ( ALU).

He was chief financial officer at Lucent for five years and was briefly chief operating officer before Lucent merged with Alcatel. He started in 1979 at AT&T Bell Labs.

Pfizer is one of several major drugmakers, including Merck ( MRK), Wyeth ( WYE) and Amgen ( AMGN), that have announced new CFOs in recent months.

AstraZeneca ( AZN) is searching for a new CFO to replace Jon Symonds, who left in July.

If you liked this article you might like

Are Fund Managers Better Than Their Funds?

Are Fund Managers Better Than Their Funds?

Can Regional Brokers Keep Outperforming?

Can Regional Brokers Keep Outperforming?

Wyeth Deal's Big, but Pfizer Still Needs a Blockbuster

Wyeth Deal's Big, but Pfizer Still Needs a Blockbuster

Cosmetic Surgery Stocks Keep Stiff Upper Lip

Cosmetic Surgery Stocks Keep Stiff Upper Lip

For Abbott, Diversity Remains Paramount

For Abbott, Diversity Remains Paramount